Literature DB >> 27366534

Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.

Ruslan Abdullayev1, Ömer Burak Küçükebe1, Recai Kaya1, Bülent Çelik2, Hatice Kuşderci1, Mehmet Duran1, Öznur Uludağ1, Mesut Öterkuş1, Aysel Buyrukcan1, Ülkü Sabuncu1, Abdullah Arpacı3.   

Abstract

OBJECTIVE: Pseudocholinesterase (PChE) is an enzyme responsible for the hydrolysis of succinylcholine. In case of its deficiency, the effect of succinylcholine that is approximately 5-10 min is prolonged up to few hours. The use of succinylcholine has been declined recently. However, it is still actively used in some special conditions and in developing countries. In this study, incidence of PChE enzyme deficiency around Adiyaman city was investigated and presented with the literature review.
METHODS: After obtaining an approval from the investigational board of our hospital (Adiyaman University Medical School, Biomedical Research Ethics Board, 30.12.2012, Nr: B.30.2.ADY.0.20.00-600/51), patients undergoing any elective operation under general anaesthesia in the Adiyaman University Medical School Hospital between March and December 2013 were recruited for the study. After obtaining the patients' written consents, blood PChE, alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, creatinine, international normalisation ratio (INR) and activated partial thromboplastin time (aPTT) values of the patients were analysed. Possible association of the PChE deficiency with other values was also investigated. The normal value of PChE was taken as 4260-11250 for females aged 16-40 years and 5320-12920 U L(-1) for other patients.
RESULTS: The study was completed with 964 patients, 702 (72.8%) of whom were females. PChE enzyme levels were under the normal in 7.2% of the patients. There were no correlation between patient group, ALT, INR, aPTT and creatinine elevation with PChE deficiency (p>0.05), whereas AST and urea level elevation was significantly associated with PChE deficiency (p<0.05). The risk of PChE deficiency was 4.5 and 9 times higher in the patients with the elevation of AST and urea levels, respectively.
CONCLUSION: Pathological elevations of AST and urea that are a part of normal pre-operative biochemical analysis of blood will indicate the possible deficiency of PChE enzyme.

Entities:  

Keywords:  Pseudocholinesterase; butyrylcholinesterase; false cholinesterase; prolonged apnoea; serum cholinesterase

Year:  2015        PMID: 27366534      PMCID: PMC4894181          DOI: 10.5152/TJAR.2015.32848

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  30 in total

1.  The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.

Authors:  D Ostergaard; S N Rasmussen; J Viby-Mogensen; N A Pedersen; R Boysen
Journal:  Anesthesiology       Date:  2000-06       Impact factor: 7.892

2.  DEPRESSED LEVELS OF SERUM-PSEUDOCHOLINESTERASE WITH ECOTHIOPHATE-IODIDE EYEDROPS.

Authors:  D D MCGAVI
Journal:  Lancet       Date:  1965-08-07       Impact factor: 79.321

3.  Reversal of prolonged suxamethonium apnoea with fresh frozen plasma in a 6-week-old infant.

Authors:  R S Gill; N O'Connell; R P Scott
Journal:  Anaesthesia       Date:  1991-12       Impact factor: 6.955

4.  Proposal for standard methods for the determination of enzyme catalytic concentrations in serum and plasma at 37 degrees C.

Authors:  E Schmidt; E Henkel; R Klauke; K Lorentz; O Sonntag; W Stein; G Weidemann; W Gerhardt
Journal:  J Clin Chem Clin Biochem       Date:  1990-10

5.  Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide.

Authors:  V Koseoglu; J Chiang; K W Chan
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

6.  Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.

Authors:  Indumathi Manoharan; Stacy Wieseler; Paul G Layer; Oksana Lockridge; Rathnam Boopathy
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

7.  A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India.

Authors:  Indumathi Manoharan; Rathnam Boopathy; Sultan Darvesh; Oksana Lockridge
Journal:  Clin Chim Acta       Date:  2006-11-17       Impact factor: 3.786

8.  Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning.

Authors:  E B Sener; E Ustun; S Kocamanoglu; A Tur
Journal:  Acta Anaesthesiol Scand       Date:  2002-09       Impact factor: 2.105

9.  Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase.

Authors:  D Ostergaard; F S Jensen; J Viby-Mogensen
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892

10.  Prolonged neuromuscular blockade as a result of malnutrition-induced pseudocholinesterase deficiency.

Authors:  Ahtsham Niazi; Irene E Leonard; Breda O'Kelly
Journal:  J Clin Anesth       Date:  2004-02       Impact factor: 9.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.